Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadezhda Viacheslavovna Elkina has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative assessment of diagnostic value of microRNAs for detection of colorectal cancer in adults: results of systematic review and network meta-analysis

    by E. A. Grivachev, Гривачев Е. А., A. A. Tryakin, Трякин А. А., S. V. Vinokurova, Винокурова С. В., K. V. Sapozhnikov, Сапожников К. В., E. S. Obarevich, Обаревич Е. С., et al.

    Background. Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, and early detection is crucial for improving patient outcomes. Circulating microRNAs have emerged as promising non-invasive biomarkers; however, comparative evaluation of their diagnostic performance, particularly in combination panels, remains limited. Aim. To compare the diagnostic value of circulating microRNAs and their combinations for early colorectal cancer detection in adults using network meta-analysis approach. Materials and methods. A systematic review and network meta-analysis of studies identified through the PubMed and Embase databases was conducted. The primary outcomes included the area under the ROC curve (AUC), sensitivity, specificity, accuracy, and surface under the cumulative ranking curve (SUCRA). Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. Statistical analyses were performed using the R software environment. Results. The included studies demonstrated substantial methodological and clinical heterogeneity (predominance of case – control design, variability in sample types and cohort characteristics), accompanied by high statistical heterogeneity in the network for AUC (I2 = 74.8 %). According to the network comparison, the most promising single biomarkers were miRNA-760 and miRNA-221, which achieved the highest SUCRA rankings (0.773 and 0.753, respectively). The most extensively studied miRNA-21 showed intermediate performance (SUCRA = 0.677). The highest diagnostic performance was observed for multi-biomarker panels: miRNA-21 + miRNA-25 + miRNA-18a + miRNA-22 (0.888), miRNA-21 + miRNA-92a + miRNA-221 (0.797), and miRNA-21 + miRNA-221 + miRNA-150 (0.797). Conclusion. Circulating microRNAs represent a promising approach for non-invasive early detection of colorectal cancer. The most relevant candidates include miRNA-760, miRNA-221, and high-performing microRNA panels. Clinical implementation requires further prospective clinical validation and standardization of the analytical methods.

  • Open Access

    Identification of microRNA biomarkers for the early detection and differential diagnosis of colorectal cancer

    by Evgeny A. Grivachev, Гривачев Евгений Александрович, M. D. Fedorova, Федорова М. Д., N. V. Elkina, Елкина Н. В., S. V. Vinokurova, Винокурова С. В., O. V. Morozova, Морозова О. В., et al.

    Introduction. Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality in both men and women. Early detection is crucial for improving patient outcomes; however, currently available screening methods are often invasive and demonstrate suboptimal diagnostic accuracy, limiting their applicability in the general population. In recent years, microRNAs (miRNAs) have attracted considerable attention as promising biomarkers for early CRC detection, with potential clinical implementation that may contribute to reduced mortality. Aim. To analyze miRNA expression in tissues of patients with colorectal cancer and colorectal adenomas in order to identify promising biomarkers for the development of diagnostic tools for CRC. Materials and methods. The study was performed using archival formalin-fixed paraffin-embedded colon tissue samples. Total RNA, including small RNAs, was isolated following enrichment of the target epithelium by microdissection. Expression levels of miR-21-5p, -23a-3p, -92a-3p, -17-5p, -451a, -1246, 135b-5p, and the reference -210-3p were analyzed using the stem-loop detection method. Relative expression was calculated using the –ΔΔCt method. Statistical significance of intergroup differences was assessed using the Mann–Whitney U test, while diagnostic performance was evaluated by ROC analysis with calculation of area under the curve (AUC), sensitivity, and specificity. Results. MiR-17-5p, -21-5p, -92a-3p, -135b-5p, and -1246 demonstrated high diagnostic potential, with expression levels significantly elevated in adenomas and adenocarcinomas compared with conditionally normal epithelium. MiR-17-5p was of particular interest, as its intermediate expression level in adenomas suggests involvement in the early stages of tumor progression. In ROC analysis, miR-17-5p demonstrated high sensitivity and specificity both for differentiating CRC from normal tissue and for distinguishing adenomas from adenocarcinomas. In addition, miR-17-5p and miR-23a-3p effectively differentiated adenomas from both normal and tumor tissues. Conclusion. The identified miRNAs, particularly miR-17-5p, -21-5p, -92a-3p, -135b-5p, and -1246, represent a promising basis for the development of diagnostic miRNA panels. Further investigation of tissue and extracellular levels of these miRNAs may facilitate the development of minimally invasive diagnostic and monitoring tests for CRC and colorectal adenomas, as well as enable evaluation of the prognostic significance of these biomarkers.

  • Open Access

    Continuous uptake of miR-181a-2 mimetic induces constitutive overexpression of cellular miR-181a-2 in MCF-7 breast cancer cells: links with progression of drug resistance

    by Olga Evgenievna Andreeva, Danila Vladimirovich Sorokin, Svetlana Vladimirovna Vinokurova, Pavel Borisovich Kopnin, Nadezhda Viacheslavovna Elkina, Danila Sergeevich Elkin, Maria Dmitrievna Fedorova, Alexander Mikhailovich Scherbakov, Mikhail Aleksandrovich Krasil’nIkov

    Purpose: The aim of this study was to elucidate the mechanisms underlying the formation and maintenance of drug resistance in cancer cells. Previously, we demonstrated that prolonged treatment of estrogen-dependent MCF-7 breast cancer cells with exosomes derived from estrogen-resistant MCF-7/T cells leads to a partial loss of estrogen sensitivity in MCF-7 cells. Moreover, repeated transfection with one of the exosomal microRNAs — microRNA-181a-2 — induced an irreversible decrease in hormonal sensitivity in the recipient cells. In the present work, to further investigate the possible mechanism of miR-181a-2-induced acquired resistance, we analyzed the effect of multiple miR-181a-2 transfections on the expression of cellular miR-181a-2 and related signaling proteins. Methods: MTT-assay, transient transfection, lentiviral infection, qRT-PCR, immunoblotting, and reporter assay. Results: We found that multiple transfections with miR-181a-2 resulted in a marked increase in cellular miR-181a-2 precursor levels, whereas single transfection had no such effect. Similarly, stable transfection with miR-181a-2 led to increased levels of cellular miR-181a-2 and its host gene, MIR181A2HG, which was associated with partial resistance to tamoxifen. Analysis of the genomic DNA encoding miR-181a-2 revealed no changes in copy number in transfected cells. Furthermore, we identified the transcription factor Snail as a key mediator of miR-181a-2–induced resistance and demonstrated its role in the formation of an autoregulatory loop of miR-181a-2 and the maintenance of cell resistance. Conclusion: Overall, these results reveal a novel mechanism of resistance-associated signaling pathway rearrangement based on the formation of a miR-181a-2 autoregulatory loop.

  • Open Access

    Search for new microRNAs for differential diagnosis of teratomas

    by K. S. Nemtseva, V. B. Matveev, N. V. Elkina, M. D. Fedorova, D. S. Elkin, O. A. Khalmurzaev, M. I. Beyshembaev, G. A. Arakelyan, S. V. Vinokurova

    Aim. Search for new microRNAs as markers for differential diagnosis of teratoma and live tumor tissues.Materials and methods. In the study, freshly frozen tissue samples obtained after orchifuniculectomy (n = 46) and retroperitoneal lymph node dissection (n = 42) in patients with TGCT diagnosis were analyzed. MicroRNAs were isolated from tissue samples and analyzed using reverse transcription polymerase chain reaction.Results. After studying the Cancer Genome Atlas, microRNA-196a-5p and microRNA-200b-3p with differential expression in tissue samples of different histological types of TGCT were identified. These microRNA are significantly overexpressed in non-seminomas, and their expression levels significantly differ from expression levels in normal tissues and seminomas. The level of microRNA-196b-5p expression in teratomas obtained after retroperitoneal lymph node dissection is significantly higher than in seminomas, and microRNA-200b-3p expression level is significantly higher than in tissues with necrotic changes. ROC analysis has shown 89 % sensitivity and 79 % specificity for microRNA-196b-5p as a diagnostic marker. For microRNA-200b-3p, sensitivity and specificity were 75 and 89 %, respectively.Conclusion. In this study, we have shown for the first time that microRNA-196a-5p and microRNA-200b-3p have high diagnostic potential as markers for identification of various types of TGCTs including teratoma.

  • Open Access

    Viral microRNA in HPV16-associated cervical cancer: expression, diagnostic potential, and biological functions

    by Nadezhda V. Elkina, Mariya D. Fedorova, Radik S. Faskhutdinov, Iuliia O. Iurchenko, Kirill I. Zhordania, Ekaterina A. Mustafina, Larisa S. Pavlova, Svetlana V. Vinokurova, Юрченко Юлия Олеговна

    BACKGROUND: Cervical cancer (CC) is the fourth most common cancer among women worldwide in terms of incidence and mortality. High-risk human papillomaviruses (HPVs) are etiologic factor of CC in more than 90% of cases, with type 16 HPV (HPV16) revealed in 50% of cancers. Dysregulation of expression of viral oncogenes E6 and E7 is the main cause of malignant transformation in infected cervical epithelial cells. The mechanisms of impaired expression of these genes are still underexplored. The dysfunction of viral microRNAs may be among the underlying factors. AIM: To analyze the expression of HPV16-associated microRNA-H1 and microRNA-H2 in cervical cancer specimens, evaluate the correlation of their expression to viral load and overall patient survival, and analyze in silico their potential viral and cellular targets. MATERIALS AND METHODS: The expression of HPV16 microRNA-H1 and HPV16 microRNA-H2 was evaluated in the real-time polymerase chain reaction. With this purpose, small RNAs were isolated from 36 specimens of HPV16-positive squamous cell carcinomas of the cervix. Further, the viral load was assessed after calculating the value of HPV16 DNA copies per cell. The association between microRNA expression and the viral load was evaluated using the nonparametric Spearman’s correlation coefficient. Kaplan-Meier curves were plotted to analyze the dependence of 5-year overall survival on the level of viral microRNA expression. The miRanda algorithm and online services mirDB, MR-microT and TargetScan Custom 5.2 were used for in silico search of theoretical microRNA targets. RESULTS: MicroRNA-H1 expression was revealed in 33 of 38 specimens (86.8%), microRNA-H2 was detected in 37 of 38 specimens (97.4%) of HPV16-positive cervical cancer. There was a positive correlation between both microRNA-H1 (r=0.36, p=0.042) and microRNA-H2 (r=0.51, p=0.001) expression and HPV16 viral load. Higher level of expression of viral microRNA-H1 and microRNA-H2 tended to correlate with better overall patient survival. The theoretical microRNA-H1 (E7, E2, E5, L2 and URR) and microRNA-H2 (E1, E2, E5, L2, L1, URR) targets in the HPV16 genome were identified in silico, as well as theoretical cellular targets indicating possible regulation of cellular signaling pathways by means of viral microRNAs, both controlling normal viral cycle and promoting tumor transformation. CONCLUSION: The results of this study demonstrate promising further investigation of the functions of viral microRNAs in relation with the infectious process and virus-induced malignant transformation, and their potential importance in the diagnosis of HPV16-associated cancers.


  • Open Access

    Diagnostic potential of miRNA-135A1 in human papillomavirus associated cervical lesions

    by D. S. Elkin, M. I. Taubinskaya, N. V. Elkina, R. S. Faskhutdinov, M. D. Fedorova, A. N. Katargin, K. I. Zhordania, E. A. Mustafina, E. A. Grivachev, L. S. Pavlova, et al.

    Introduction. Human papillomavirus (HPV) infection with high-risk HPVs is an etiological factor in the development of cervical cancer, with HPV type 16 (HPV16) being the most common. The mechanisms leading to disruption of viral oncogene expression and initiation of epithelial cell transformation are poorly understood. Epigenetic regulatory factors, including cellular miRNAs, may play an important role in HPV-induced carcinogenesis, and aberrantly expressed miRNAs may be promising markers for the diagnosis of HPV-associated lesions.Aim. To search for miRNAs involved in the pathogenesis of HPV16-associated cervical cancer and to evaluate their diagnostic potential for the detection of cervical cancer and precancerous lesions.Materials and methods. MiRNA expression in clinical samples was assessed by both next generation sequencing and quantitative stem-loop polymerase chain reaction (sl-qPCR). Plasma miRNAs from patients with precancerous and cancerous lesions and healthy donors were analyzed using sl-qPCR. Loss of heterozygosity in cervical cancer samples was assessed by copy number ratio of MIR135A1 and ACTB genes. A total of 67 patients with cervical cancer, 21 with precancerous cervical lesions and 24 healthy donors were included in the study. The effect of DNA methylation on miRNA-135A1 expression was evaluated after treatment with a demethylating agent of the cervical HPV16-positive SiHa cell line. Changes in the expression of the HPV16 E6 oncogene were analyzed after transfection with synthetic analogues of the mature forms of miRNA-135А1 (miRNA-135a-3p and miRNA-135a-5p).Results. A significant decrease in the expression of miRNA-135A1 and miRNA-135A2 was detected in tumor tissue samples from HPV16-positive cervical cancer, which was confirmed by sl-qPCR in an independent panel of tumor samples. A decrease in miRNA-135A1 expression was shown to result from both loss of heterozygosity of the gene and aberrant DNA methylation. Transfection of mature forms of miRNA-135A1 into SiHa cells resulted in decreased expression of the E6 oncogene of HPV16. Blood plasma samples from patients with cervical cancer and precancerous lesions showed lower levels of miRNA-135a-3p than healthy donors, and ROC analysis indicated its high diagnostic potential.Conclusion. Levels of miRNA-135A1 are significantly reduced in cervical lesions, both in tumor tissue and plasma, and the ability of this miRNA to suppress the expression of the HPV16 E6 oncogene suggests its oncosuppressive properties. Thus, miRNA-135A1 can be used as a promising new marker for the diagnosis of HPV-associated lesions.


  • Open Access

    The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells

    by O. E. Andreeva, D. V. Sorokin, S. V. Vinokurova, Yu. Yu. Shchegolev, N. V. Elkina, A. N. Katargin, R. S. Faskhutdinov, Д. И. Сальникова, A. M. Scherbakov, M. A. Krasil’nIkov, et al.

    Introduction. Rearrangement of molecular pathways and activation of bypass signaling determine the progression of tumor cell resistance to various drugs. Study of the common features of resistant formation mechanisms is essential for breast and other cancer beneficial treatments.Materials and methods. The present work was performed on estrogen receptor α ERα-positive (ERα – estrogen receptor α) McF-7 breast cancer cells, established sublines resistant to the mTOR inhibitor rapamycin or antiestrogen tamoxifen, and ERα-negative MDA-MB-231 breast cancer cells. Methods used include MTT test, transient transfection, immunoblotting, real-time polymerase chain reaction and methylation analysis by bisulfite pyrosequencing.Results. We have shown that the resistance of breast cancer cells to targeted and hormonal drugs is associated with the suppression of DNA methyltransferase 3A (DNMT3A) and respective changes in DNA methylation; DNMT3A knockdown results in the partial resistance to both drugs demonstrating the pivotal role of DNMT3A suppression in the progression of cell resistance.Conclusion. Totally, the results obtained highlight the possible mechanism of tumor cell resistance to targeting/hormonal drugs based on the deregulation of DNMTs expression and demonstrate direct connection between DNMT3A suppression and resistance progression.


  • Open Access

    Identification regulatory noncoding RNAs of human papilloma virus type 16 (Papillomaviridae: Alphapapillomavirus: Human papillomavirus) in cervical tumors

    by Natalia P. Kisseljova, Maria D. Fedorova, Anastasia E. Zaikina, Nadezhda V. Elkina, Ekaterina E. Goldobina, Danila S. Elkin, Pavel M. Abramov, Larisa S. Pavlova, Svetlana V. Vinokurova

    Introduction. High carcinogenic-risk human papillomaviruses (hrHPVs) are recognized as etiological agents of cervical cancer. Constant expression of the viral oncoproteins, E6 and E7, is required for maintenance of the malignant phenotype of tumor cells. The exact mechanism of regulation of viral oncogenes expression in tumor cells is not fully elucidated. The purpose: identification of viral noncoding RNAs (ncRNAs) in HPV16-positve cervical cancer. Materials and methods. The reverse transcription polymerase chain reactions were used to detect viral ncRNAs in HPV16-positve primary cervical squamous cell carcinomas and SiHa and CasKi cell lines. The knockdown technique with oligonucleotides complementary to ncRNAs was used to elucidate their functions. Results. We have identified ncRNAs transcribed in the upstream regulatory region of HPV16 in the cervical carcinoma cell lines and in 32 out 32 cervical squamous cell carcinomas with episomal or integrated forms of HPV16 DNA. Knockdown of sense or antisense strains of ncRNAs by oligonucleotides results in a decrease or increase of the E6 and E7 oncogenes mRNA levels in cells, respectively. These changes of oncogenes mRNA levels are accompanied by the modulation of the levels of the p53 protein, the main target of the E6 oncoprotein. Conclusion. The presence of regulatory ncRNAs in all examined tumors and cell lines revealed for the first time indicates their necessity for maintenance of constant expression of E6 and E7 oncogenes in them. The findings can be useful for understanding of the fundamental aspects of the viral expression regulation in HPV16-positive tumors.


  • Open Access

    Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers

    by Gleb O. Skryabin, Andrey V. Komelkov, Kirill I. Zhordania, Dmitry V. Bagrov, Svetlana V. Vinokurova, Sergey A. Galetsky, Nadezhda V. Elkina, Darya A. Denisova, Adel D. Enikeev, Elena M. Tchevkina

    Extracellular vesicles (EVs), including exosomes, are key factors of intercellular communication, performing both local and distant transfers of bioactive molecules. The increasingly obvious role of EVs in carcinogenesis, similarity of molecular signatures with parental cells, precise selection and high stability of cargo molecules make exosomes a promising source of liquid biopsy markers for cancer diagnosis. The uterine cavity fluid, unlike blood, urine and other body fluids commonly used to study EVs, is of local origin and therefore enriched in EVs secreted by cells of the female reproductive tract. Here, we show that EVs, including those corresponding to exosomes, could be isolated from individual samples of uterine aspirates (UA) obtained from epithelial ovarian cancer (EOC) patients and healthy donors using the ultracentrifugation technique. First, the conducted profiling of small RNAs (small RNA-seq) from UA-derived EVs demonstrated the presence of non-coding RNA molecules belonging to various classes. The analysis of the miRNA content in EVs from UA performed on a pilot sample revealed significant differences in the expression levels of a number of miRNAs in EVs obtained from EOC patients compared to healthy individuals. The results open up prospects for using UA-derived EVs as a source of markers for the diagnostics of gynecological cancers, including EOC.